{
    "medicine_id": "35437584b6b5621a4779482495c073dba26a080f",
    "platform_id": "DB05730",
    "metadata": {
        "name": "Stelara 5 mg Solution",
        "composition": "5 mg PMI 001",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in rheumatoid arthritis",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "PMI 001 is a novel orally bioavailable small molecule based plant derived multi component disease modifying agent currently being developed for rheumatoid arthritis Potential applications of this drug candidate beyond rheumatoid arthritis include a wide range of autoimmune disorders including psoriasis lupus inflammatory bowel disease IBD and multiple sclerosis MS",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}